Skip to main content
Clinical Trials/ITMCTR2100005025
ITMCTR2100005025
Not yet recruiting
Phase 1

A Study Evaluating the Clinical Efficacy of Treatment based on Chinese Medicine Guideline in Patients With Myasthenia Gravis

The Affiliated Hospital of Changchun University of Traditional Chinese Medicine0 sitesTBD

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Not specified
Sponsor
The Affiliated Hospital of Changchun University of Traditional Chinese Medicine
Status
Not yet recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Observational study
Sex
All

Investigators

Sponsor
The Affiliated Hospital of Changchun University of Traditional Chinese Medicine

Eligibility Criteria

Inclusion Criteria

  • 1\.Age is not limited, gender is not limited;
  • 2\.Clinical MG manifestations, and or neostigmine test positive, low frequency repeated electrical stimulation positive, serum AChR, Musk, LRP4, Titin, RyR and other antibodies are positive, clinical diagnosis of myasthenia gravis can be diagnosed;
  • 3\.Patients with myasthenia gravis classified as type I, type II (type IIa, type IIb), III (type IIIa, type IIIb) and IV (type IVa, IVb) in clinical MGFA;
  • 4\.Agree to participate in this study and sign an informed consent form.

Exclusion Criteria

  • 1\.Patients with severe medical diseases: severe arrhythmia, severe lung disease, ALT/AST\> 2 times the normal value, Cr\> 2 times the normal value;
  • 2\.Patients with malignant tumors (excluding thymoma), history of HIV infection, or severe immunodeficiency;
  • 3\.Female patients who are pregnant, breastfeeding or breastfeeding;
  • 4\.History of mental illness;
  • 5\.Tuberculosis patients with tuberculin test or T\-SPOT test positive.

Outcomes

Primary Outcomes

Not specified

Similar Trials